D
Vext Science, Inc.
VEXTF
$0.1058
-$0.0007-0.66%
D
Sell
6/11/2024Downgrade
Vext Science, Inc. (VEXTF) was downgraded to D from C- on 6/11/2024 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 212.53% from $5.63M to -$6.33M, earnings per share declined from $0.0269 to -$0.03, and operating cash flow declined 82.29% from $615.4 to $109.
Vext Science, Inc. (VEXTF) was downgraded to D from C- on 6/11/2024 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 212.53% from $5.63M to -$6.33M, earnings per share declined from $0.0269 to -$0.03, and operating cash flow declined 82.29% from $615.4 to $109.
C
Hold
5/28/2024Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 5/28/2024 due to a noticeable increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.0123 to $0.0269, operating cash flow increased 70.75% from $360.4 to $615.4, and debt to equity declined from 0.55 to 0.38.
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 5/28/2024 due to a noticeable increase in the growth index, solvency index and total return index. Earnings per share increased from -$0.0123 to $0.0269, operating cash flow increased 70.75% from $360.4 to $615.4, and debt to equity declined from 0.55 to 0.38.
D
Sell
11/30/2023Downgrade
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 11/30/2023 due to a significant decline in the growth index, efficiency index and valuation index. Net income declined 443.27% from $535.5 to -$1.84M, earnings per share declined from $0.0036 to -$0.0123, and EBIT declined 351.23% from $683.2 to -$1.72M.
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 11/30/2023 due to a significant decline in the growth index, efficiency index and valuation index. Net income declined 443.27% from $535.5 to -$1.84M, earnings per share declined from $0.0036 to -$0.0123, and EBIT declined 351.23% from $683.2 to -$1.72M.
C
Hold
11/15/2023Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 11/15/2023 due to a large increase in the growth index, solvency index and total return index. Operating cash flow increased 666.78% from $397.9 to $3.05M, earnings per share increased from $0.0005 to $0.0036, and the quick ratio increased from 0.79 to 0.91.
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 11/15/2023 due to a large increase in the growth index, solvency index and total return index. Operating cash flow increased 666.78% from $397.9 to $3.05M, earnings per share increased from $0.0005 to $0.0036, and the quick ratio increased from 0.79 to 0.91.
D
Sell
7/26/2023Downgrade
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 7/26/2023 due to a decline in the total return index.
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 7/26/2023 due to a decline in the total return index.
C
Hold
7/10/2023Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 7/10/2023 due to an increase in the volatility index and total return index.
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 7/10/2023 due to an increase in the volatility index and total return index.
D
Sell
6/6/2023Downgrade
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 6/6/2023 due to a major decline in the growth index, volatility index and total return index. Earnings per share declined from $0.0446 to $0.0005, operating cash flow declined 86.12% from $2.87M to $397.9, and EBIT declined 12.77% from $939.9 to $819.9.
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 6/6/2023 due to a major decline in the growth index, volatility index and total return index. Earnings per share declined from $0.0446 to $0.0005, operating cash flow declined 86.12% from $2.87M to $397.9, and EBIT declined 12.77% from $939.9 to $819.9.
C
Hold
5/11/2023Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 5/11/2023 due to an increase in the total return index and volatility index.
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 5/11/2023 due to an increase in the total return index and volatility index.
D
Sell
4/26/2023Downgrade
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 4/26/2023 due to a decline in the volatility index and valuation index.
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 4/26/2023 due to a decline in the volatility index and valuation index.
C
Hold
4/6/2023Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 4/6/2023 due to a significant increase in the growth index, volatility index and efficiency index. Earnings per share increased from $0.003 to $0.0446, net income increased 1,385.34% from $423.5 to $6.29M, and operating cash flow increased 400.82% from -$952.7 to $2.87M.
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 4/6/2023 due to a significant increase in the growth index, volatility index and efficiency index. Earnings per share increased from $0.003 to $0.0446, net income increased 1,385.34% from $423.5 to $6.29M, and operating cash flow increased 400.82% from -$952.7 to $2.87M.
D
Sell
1/23/2023Upgraded
Vext Science, Inc. (VEXTF) was upgraded to D+ from D on 1/23/2023 due to an increase in the volatility index.
Vext Science, Inc. (VEXTF) was upgraded to D+ from D on 1/23/2023 due to an increase in the volatility index.
D
Sell
11/16/2022Downgrade
Vext Science, Inc. (VEXTF) was downgraded to D from D+ on 11/16/2022 due to a decline in the total return index and volatility index.
Vext Science, Inc. (VEXTF) was downgraded to D from D+ on 11/16/2022 due to a decline in the total return index and volatility index.
D
Sell
8/25/2022Downgrade
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 8/25/2022 due to a decline in the total return index, solvency index and valuation index. The quick ratio declined from 0.51 to 0.3.
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 8/25/2022 due to a decline in the total return index, solvency index and valuation index. The quick ratio declined from 0.51 to 0.3.
C
Hold
8/22/2022Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 8/22/2022 due to an increase in the total return index and valuation index.
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 8/22/2022 due to an increase in the total return index and valuation index.
D
Sell
7/18/2022Downgrade
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 7/18/2022 due to a noticeable decline in the total return index, growth index and solvency index. The quick ratio declined from 2.97 to 0.51, and operating cash flow declined 35.08% from $4.75M to $3.09M.
Vext Science, Inc. (VEXTF) was downgraded to D+ from C- on 7/18/2022 due to a noticeable decline in the total return index, growth index and solvency index. The quick ratio declined from 2.97 to 0.51, and operating cash flow declined 35.08% from $4.75M to $3.09M.
C
Hold
5/16/2022Downgrade
Vext Science, Inc. (VEXTF) was downgraded to C- from C on 5/16/2022 due to a decline in the volatility index, solvency index and total return index.
Vext Science, Inc. (VEXTF) was downgraded to C- from C on 5/16/2022 due to a decline in the volatility index, solvency index and total return index.
C
Hold
4/25/2022Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C from C- on 4/25/2022 due to an increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.26 to 0.23.
Vext Science, Inc. (VEXTF) was upgraded to C from C- on 4/25/2022 due to an increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.26 to 0.23.
C
Hold
1/27/2022Downgrade
Vext Science, Inc. (VEXTF) was downgraded to C- from C on 1/27/2022 due to a large decline in the total return index and volatility index.
Vext Science, Inc. (VEXTF) was downgraded to C- from C on 1/27/2022 due to a large decline in the total return index and volatility index.
C
Hold
6/1/2021Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C from C- on 6/1/2021 due to a major increase in the valuation index, growth index and solvency index. Operating cash flow increased 87.72% from $1.23M to $2.31M, the quick ratio increased from 2.23 to 3.63, and total revenue increased 42.92% from $6.41M to $9.16M.
Vext Science, Inc. (VEXTF) was upgraded to C from C- on 6/1/2021 due to a major increase in the valuation index, growth index and solvency index. Operating cash flow increased 87.72% from $1.23M to $2.31M, the quick ratio increased from 2.23 to 3.63, and total revenue increased 42.92% from $6.41M to $9.16M.
C
Hold
4/16/2021Upgraded
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 4/16/2021 due to a significant increase in the valuation index, total return index and efficiency index. Total capital increased 10.54% from $43.24M to $47.8M.
Vext Science, Inc. (VEXTF) was upgraded to C- from D+ on 4/16/2021 due to a significant increase in the valuation index, total return index and efficiency index. Total capital increased 10.54% from $43.24M to $47.8M.
D
Sell
12/24/2020Upgraded
Vext Science, Inc. (VEXTF) was upgraded to D+ from D on 12/24/2020 due to a large increase in the growth index, volatility index and total return index. Operating cash flow increased 270.56% from $613.2 to $2.27M, earnings per share increased from $0.0062 to $0.0167, and EBIT increased 57.56% from $1.02M to $1.61M.
Vext Science, Inc. (VEXTF) was upgraded to D+ from D on 12/24/2020 due to a large increase in the growth index, volatility index and total return index. Operating cash flow increased 270.56% from $613.2 to $2.27M, earnings per share increased from $0.0062 to $0.0167, and EBIT increased 57.56% from $1.02M to $1.61M.
D
Sell
6/2/2020Upgraded
Vext Science, Inc. (VEXTF) was upgraded to D from D- on 6/2/2020 due to a noticeable increase in the valuation index.
Vext Science, Inc. (VEXTF) was upgraded to D from D- on 6/2/2020 due to a noticeable increase in the valuation index.
D
Sell
2/6/2020Upgraded
Vext Science, Inc. (VEXTF) was upgraded to D- from E on 2/6/2020 due to a noticeable increase in the solvency index, valuation index and efficiency index. Total capital increased 3.13% from $26.21M to $27.03M.
Vext Science, Inc. (VEXTF) was upgraded to D- from E on 2/6/2020 due to a noticeable increase in the solvency index, valuation index and efficiency index. Total capital increased 3.13% from $26.21M to $27.03M.
E
Sell
11/5/2019Upgraded
Vapen MJ Ventures Corporation (VAPNF) was upgraded to E from E- on 11/5/2019 due to a noticeable increase in the valuation index.
Vapen MJ Ventures Corporation (VAPNF) was upgraded to E from E- on 11/5/2019 due to a noticeable increase in the valuation index.
E
Sell
9/30/2019None
Vext Science, Inc. (VEXTF) was downgraded to E- from U on 09/30/2019.
Vext Science, Inc. (VEXTF) was downgraded to E- from U on 09/30/2019.
OTC PK
03/07/2025 1:55PM Eastern
Quotes delayed
